30-01-2023 ASH Highlights: Monoclonal / Bispecific antibodies, Complement Cascade
30-01-2023 ASH Highlights: Monoclonal / Bispecific antibodies, Complement Cascade Read More »
In this Deep Dive Session, Prof. Mohamad Mohty discusses the latest advancements in the treatment of multiple myeloma, including the use of novel therapies and the importance of genetic testing
17-10-2022 Approaches to management of refractory-relapsed Multiple Myeloma Read More »
In this Deep Dive Session, Prof. Laurie Sehn, a haematologist based at the British Colombia Cancer Center for Lymphoid Cancer, provides a comprehensive overview of the current landscape of Diffuse
10-10-2022 The evolving treatment landscape in DLBCL Read More »
In this Deep Dive Session, Dr. Romana Jassat and Dr. Garrick Laudin present a comprehensive overview of Gray Zone Lymphoma, a rare and challenging disease entity that straddles the characteristics
22-08-2022 Grey Zone Lymphoma Read More »
In this Deep Dive Session, Prof. Pier Luigi Zinzani, from the University of Bologna, discusses the use of PD-1 inhibitors in the treatment of relapsed or refractory Hodgkin’s lymphoma. He
27-06-2022 Relapsed Refractory Hodgkin Lymphoma management Read More »
In this Deep Dive Session, Dr. Johnny Mahlangu and Dr. Susan Louw discuss the evolution of hemophilia treatment, focusing on the transition from prophylaxis with factor replacement therapy to non-factor
20-06-2022 Haemophilia treatment and laboratory diagnostics a new era Read More »
In this Deep Dive Session, Professor Arnon Kater from the University of Amsterdam provides an in-depth discussion on the treatment of chronic lymphocytic leukemia (CLL) with a focus on novel
09-05-2022 Approach to high risk CLL with Prof Arnon Kater Read More »
In this Deep Dive Session, Dr. H Dewa and Dr Gugu Jali discuss various aspects of Myelodysplastic Syndromes (MDS), presenting several case studies and discussing their diagnosis and management. They
25-04-2022 Myelodysplastic Syndrome led by UKZN Team Read More »
In this Deep Dive Session, Garrick Laudin, Nandipha Sigedle, and Jenifer Vaughan present on Acute Lymphoblastic Leukaemia (ALL). The discussion focuses on the genetic risk factors, particularly the translocation 1;19,
28-02-2022 Acute Lymphoblastic Leukaemia Read More »